Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last C$7.47 CAD
Change Today -0.12 / -1.58%
Volume 1.2K
RX On Other Exchanges
Symbol
Exchange
OTC US
Venture
As of 10:19 AM 06/30/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for biosyent inc (RX)

View Cash Flow In U.S. Dollar
Currency in
Millions of Canadian Dollars
As of:Dec 31
2011
Restated
CAD
Dec 31
2012
CAD
Dec 31
2013
Restated
CAD
Dec 31
2014
CAD
4 Year
Trend
NET INCOME0.41.51.93.2
Depreciation & Amortization0.00.00.00.0
Amortization of Goodwill and Intangible Assets0.00.0----
DEPRECIATION & AMORTIZATION, TOTAL0.00.00.00.0
Amortization of Deferred Charges0.00.00.00.0
Other Operating Activities0.0-0.20.30.0
Change in Accounts Receivable0.0-0.30.0-0.1
Change in Inventories-0.1-0.2-0.2-0.7
Change in Accounts Payable0.20.30.01.2
Change in Other Working Capital0.00.0-0.1-0.1
CASH FROM OPERATIONS0.61.22.23.6
Capital Expenditure0.0-0.1-0.1-0.1
Sale (Purchase) of Intangible Assets0.0---0.10.0
Investments in Marketable & Equity Securities-------1.0
CASH FROM INVESTING0.0-0.1-0.1-1.1
Issuance of Common Stock0.00.10.00.0
Other Financing Activities0.00.0----
CASH FROM FINANCING0.00.10.00.0
Foreign Exchange Rate Adjustments--0.00.00.0
Miscellaneous Cash Flow Adjustments--0.0----
NET CHANGE IN CASH0.61.32.12.6
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RX:CN C$7.47 CAD -0.12

RX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for RX.
View Industry Companies
 

Industry Analysis

RX

Industry Average

Valuation RX Industry Range
Price/Earnings 31.9x
Price/Sales 8.5x
Price/Book 12.0x
Price/Cash Flow 30.9x
TEV/Sales 8.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOSYENT INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.